Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1654

1.

Late incidence and determinants of stroke after aortic and mitral valve replacement.

Ruel M, Masters RG, Rubens FD, Bédard PJ, Pipe AL, Goldstein WG, Hendry PJ, Mesana TG.

Ann Thorac Surg. 2004 Jul;78(1):77-83; discussion 83-4.

PMID:
15223407
2.

Late incidence and determinants of reoperation in patients with prosthetic heart valves.

Ruel M, Kulik A, Rubens FD, Bédard P, Masters RG, Pipe AL, Mesana TG.

Eur J Cardiothorac Surg. 2004 Mar;25(3):364-70.

PMID:
15019662
3.

Long-term outcomes of valve replacement with modern prostheses in young adults.

Ruel M, Kulik A, Lam BK, Rubens FD, Hendry PJ, Masters RG, Bédard P, Mesana TG.

Eur J Cardiothorac Surg. 2005 Mar;27(3):425-33; discussion 433. Epub 2004 Dec 30.

PMID:
15740951
4.

Early and late stroke after mitral valve replacement with a mechanical prosthesis: risk factor analysis of a 24-year experience.

Bando K, Kobayashi J, Hirata M, Satoh T, Niwaya K, Tagusari O, Nakatani S, Yagihara T, Kitamura S.

J Thorac Cardiovasc Surg. 2003 Aug;126(2):358-64.

5.

[The best of valvular heart disease in 2006].

de Gevigney G; Groupe de travail sur les valvulopathies de la Societe francaise de cardiologi.

Arch Mal Coeur Vaiss. 2007 Jan;100 Spec No 1:19-28. Review. French.

PMID:
17405561
6.

Natural history and predictors of outcome in patients with concomitant functional mitral regurgitation at the time of aortic valve replacement.

Ruel M, Kapila V, Price J, Kulik A, Burwash IG, Mesana TG.

Circulation. 2006 Jul 4;114(1 Suppl):I541-6.

7.

Late incidence and predictors of persistent or recurrent heart failure in patients with aortic prosthetic valves.

Ruel M, Rubens FD, Masters RG, Pipe AL, Bédard P, Hendry PJ, Lam BK, Burwash IG, Goldstein WG, Brais MP, Keon WJ, Mesana TG.

J Thorac Cardiovasc Surg. 2004 Jan;127(1):149-59.

8.

High risk of thromboemboli early after bioprosthetic cardiac valve replacement.

Heras M, Chesebro JH, Fuster V, Penny WJ, Grill DE, Bailey KR, Danielson GK, Orszulak TA, Pluth JR, Puga FJ, et al.

J Am Coll Cardiol. 1995 Apr;25(5):1111-9.

9.

Lower intensity anticoagulation therapy results in lower complication rates with the St. Jude Medical prosthesis.

Horstkotte D, Schulte HD, Bircks W, Strauer BE.

J Thorac Cardiovasc Surg. 1994 Apr;107(4):1136-45.

PMID:
8159036
10.

Bivalvular mechanical mitral-aortic valve replacement in 254 patients: long-term results--a 22-year follow-up.

Remadi JP, Baron O, Tribouilloy C, Roussel JC, Al-Habasch O, Despins P, Michaud JL, Duveau D.

Ann Thorac Surg. 2003 Aug;76(2):487-92.

PMID:
12902091
11.

Mechanical versus bioprosthetic valve replacement in middle-aged patients.

Kulik A, Bédard P, Lam BK, Rubens FD, Hendry PJ, Masters RG, Mesana TG, Ruel M.

Eur J Cardiothorac Surg. 2006 Sep;30(3):485-91. Epub 2006 Jul 20.

PMID:
16857373
12.

Simultaneous aortic and mitral valve replacement: predictors of adverse outcome.

Kuwaki K, Tsukamoto M, Komatsu K, Morishita K, Sakata J, Abe T.

J Heart Valve Dis. 2003 Mar;12(2):169-76.

PMID:
12701788
13.

Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.

Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BS, Petersen P.

Circulation. 2004 Oct 19;110(16):2287-92. Epub 2004 Oct 11.

14.

Long-term neurocognitive function after mechanical aortic valve replacement.

Zimpfer D, Czerny M, Schuch P, Fakin R, Madl C, Wolner E, Grimm M.

Ann Thorac Surg. 2006 Jan;81(1):29-33.

PMID:
16368330
15.

Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.

Ribeiro PA, Al Zaibag M, Idris M, Al Kasab S, Davies G, Mashat E, Wareham E, Al Fagih M.

J Thorac Cardiovasc Surg. 1986 Jan;91(1):92-8.

PMID:
3941564
16.

Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?

ElBardissi AW, DiBardino DJ, Chen FY, Yamashita MH, Cohn LH.

J Thorac Cardiovasc Surg. 2010 May;139(5):1137-45. doi: 10.1016/j.jtcvs.2009.10.064. Epub 2010 Mar 19.

17.

Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement.

Blair KL, Hatton AC, White WD, Smith LR, Lowe JE, Wolfe WG, Young WG, Oldham HN, Douglas JM Jr, Glower DD.

Circulation. 1994 Nov;90(5 Pt 2):II214-9.

PMID:
7955256
18.

Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.

Yamak B, Iscan Z, Mavitas B, Ulus AT, Katircioglu SF, Tasdemir O, Bayazit K.

J Heart Valve Dis. 1999 Nov;8(6):665-73.

PMID:
10616246
19.

Late incidence and predictors of persistent or recurrent heart failure in patients with mitral prosthetic valves.

Ruel M, Rubens FD, Masters RG, Pipe AL, Bédard P, Mesana TG.

J Thorac Cardiovasc Surg. 2004 Aug;128(2):278-83.

20.

Eleven-year single-center experience with the ATS Open Pivot Bileaflet heart valve.

Baykut D, Grize L, Schindler C, Keil AS, Bernet F, Zerkowski HR.

Ann Thorac Surg. 2006 Sep;82(3):847-52.

PMID:
16928496

Supplemental Content

Support Center